357 related articles for article (PubMed ID: 26518435)
1. Platelet transactivation by monocytes promotes thrombosis in heparin-induced thrombocytopenia.
Tutwiler V; Madeeva D; Ahn HS; Andrianova I; Hayes V; Zheng XL; Cines DB; McKenzie SE; Poncz M; Rauova L
Blood; 2016 Jan; 127(4):464-72. PubMed ID: 26518435
[TBL] [Abstract][Full Text] [Related]
2. Activation of platelets by sera containing IgG1 heparin-dependent antibodies: an explanation for the predominance of the Fc gammaRIIa "low responder" (his131) gene in patients with heparin-induced thrombocytopenia.
Denomme GA; Warkentin TE; Horsewood P; Sheppard JA; Warner MN; Kelton JG
J Lab Clin Med; 1997 Sep; 130(3):278-84. PubMed ID: 9341987
[TBL] [Abstract][Full Text] [Related]
3. Recognition of PF4-VWF complexes by heparin-induced thrombocytopenia antibodies contributes to thrombus propagation.
Johnston I; Sarkar A; Hayes V; Koma GT; Arepally GM; Chen J; Chung DW; López JA; Cines DB; Rauova L; Poncz M
Blood; 2020 Apr; 135(15):1270-1280. PubMed ID: 32077913
[TBL] [Abstract][Full Text] [Related]
4. PF4/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of FcγRI.
Kasthuri RS; Glover SL; Jonas W; McEachron T; Pawlinski R; Arepally GM; Key NS; Mackman N
Blood; 2012 May; 119(22):5285-93. PubMed ID: 22394597
[TBL] [Abstract][Full Text] [Related]
5. 5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies.
Kizlik-Masson C; Vayne C; McKenzie SE; Poupon A; Zhou Y; Champier G; Pouplard C; Gruel Y; Rollin J
J Thromb Haemost; 2017 Oct; 15(10):2065-2075. PubMed ID: 28771917
[TBL] [Abstract][Full Text] [Related]
6. Prothrombotic factors enhance heparin-induced thrombocytopenia and thrombosis in vivo in a mouse model.
Reilly MP; Taylor SM; Franklin C; Sachais BS; Cines DB; Williams KJ; McKenzie SE
J Thromb Haemost; 2006 Dec; 4(12):2687-94. PubMed ID: 16961586
[TBL] [Abstract][Full Text] [Related]
7. Role of monocytes and endothelial cells in heparin-induced thrombocytopenia.
Madeeva D; Cines DB; Poncz M; Rauova L
Thromb Haemost; 2016 Oct; 116(5):806-812. PubMed ID: 27487857
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia.
Perdomo J; Leung HHL; Ahmadi Z; Yan F; Chong JJH; Passam FH; Chong BH
Nat Commun; 2019 Mar; 10(1):1322. PubMed ID: 30899022
[TBL] [Abstract][Full Text] [Related]
9. Measurement of procoagulant platelets provides mechanistic insight and diagnostic potential in heparin-induced thrombocytopenia.
Lee CSM; Selvadurai MV; Pasalic L; Yeung J; Konda M; Kershaw GW; Favaloro EJ; Chen VM
J Thromb Haemost; 2022 Apr; 20(4):975-988. PubMed ID: 35038779
[TBL] [Abstract][Full Text] [Related]
10. Complement mediates binding and procoagulant effects of ultralarge HIT immune complexes.
Khandelwal S; Barnes A; Rauova L; Sarkar A; Rux AH; Yarovoi SV; Zaitsev SS; Lambris JD; Myoung SS; Johnson A; Lee GM; Duarte M; Poncz M; Arepally GM; Cines DB
Blood; 2021 Nov; 138(21):2106-2116. PubMed ID: 34189574
[TBL] [Abstract][Full Text] [Related]
11. Heparin-induced thrombocytopenia: a ten-year retrospective.
Warkentin TE
Annu Rev Med; 1999; 50():129-47. PubMed ID: 10073268
[TBL] [Abstract][Full Text] [Related]
12. Increased risk of thrombosis in FcγRIIA 131RR patients with HIT due to defective control of platelet activation by plasma IgG2.
Rollin J; Pouplard C; Sung HC; Leroux D; Saada A; Gouilleux-Gruart V; Thibault G; Gruel Y
Blood; 2015 Apr; 125(15):2397-404. PubMed ID: 25680756
[TBL] [Abstract][Full Text] [Related]
13. Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/thrombosis.
Visentin GP; Moghaddam M; Beery SE; McFarland JG; Aster RH
J Lab Clin Med; 2001 Jul; 138(1):22-31. PubMed ID: 11433225
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of heparin-induced thrombocytopenia and thrombosis.
Arepally G; Cines DB
Autoimmun Rev; 2002 May; 1(3):125-32. PubMed ID: 12849005
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for heparin-induced thrombocytopenia: Focus on Fcγ receptors.
Rollin J; Pouplard C; Gruel Y
Thromb Haemost; 2016 Oct; 116(5):799-805. PubMed ID: 27358188
[TBL] [Abstract][Full Text] [Related]
16. Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin-induced thrombocytopenia.
Nazy I; Clare R; Staibano P; Warkentin TE; Larché M; Moore JC; Smith JW; Whitlock RP; Kelton JG; Arnold DM
J Thromb Haemost; 2018 Jul; 16(7):1402-1412. PubMed ID: 29723924
[TBL] [Abstract][Full Text] [Related]
17. Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.
Prechel MM; Jeske WP; Walenga JM
Thromb Res; 2010 Apr; 125(4):e143-8. PubMed ID: 19931120
[TBL] [Abstract][Full Text] [Related]
18. A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.
Padmanabhan A; Jones CG; Curtis BR; Bougie DW; Sullivan MJ; Peswani N; McFarland JG; Eastwood D; Wang D; Aster RH
Chest; 2016 Sep; 150(3):506-15. PubMed ID: 26905366
[TBL] [Abstract][Full Text] [Related]
19. Cleavage of anti-PF4/heparin IgG by a bacterial protease and potential benefit in heparin-induced thrombocytopenia.
Kizlik-Masson C; Deveuve Q; Zhou Y; Vayne C; Thibault G; McKenzie SE; Pouplard C; Loyau S; Gruel Y; Rollin J
Blood; 2019 May; 133(22):2427-2435. PubMed ID: 30917957
[TBL] [Abstract][Full Text] [Related]
20. The pathophysiology of immune-mediated heparin-induced thrombocytopenia.
Reilly RF
Semin Dial; 2003; 16(1):54-60. PubMed ID: 12535302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
